PERCEPTIVE ADVISORS LLC Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$1.4T
Holdings
192
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (192 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | EX9EXELIXIS | 46,361 | $691.0M | 0.05% | |
| 102 | UTHUNITED THERAPEUTICS | 4,753 | $682.0M | 0.05% | |
| 103 | AMAGAMAG PHARMACEUTICALS | 19,524 | $679.0M | 0.05% | |
| 104 | EXASEXACT SCIENCES CORP PUT 17 01/20/2017 | 200,000 | $670.0M | 0.05% | Put |
| 105 | —INC RESEARCH HOLDINGS CLASS A | 12,636 | $665.0M | 0.05% | |
| 106 | —PROTEON THERAPEUTICS | 334,116 | $635.0M | 0.05% | |
| 107 | —METASTAT INC | 500,000 | $618.0M | 0.04% | |
| 108 | ENZBENZO BIOCHEM | 83,893 | $582.0M | 0.04% | |
| 109 | —MAGELLAN HEALTH | 7,508 | $565.0M | 0.04% | |
| 110 | STLAFIAT CHRYSLER AUTOMOBILES | 62,000 | $565.0M | 0.04% | |
| 111 | INCYINCYTE | 5,619 | $563.0M | 0.04% | |
| 112 | SCYXEURSCYNEXIS | 171,185 | $546.0M | 0.04% | |
| 113 | BIIBBIOGEN INC | 1,922 | $545.0M | 0.04% | |
| 114 | XXYCROSS COUNTRY HEALTHCARE | 34,819 | $544.0M | 0.04% | |
| 115 | HUMHUMANA INC CALL 210 04/21/2017 | 40,000 | $528.0M | 0.04% | Call |
| 116 | —ONCOBIOLOGICS INC WTS | 656,382 | $518.0M | 0.04% | |
| 117 | ICLRICON | 6,873 | $517.0M | 0.04% | |
| 118 | UNHUNITEDHEALTH GROUP | 3,223 | $516.0M | 0.04% | |
| 119 | —TRACON PHARMACEUTICALS | 100,000 | $490.0M | 0.03% | |
| 120 | HCQAMN HEALTHCARE | 12,585 | $484.0M | 0.03% | |
| 121 | —APPLIED GENETIC TECHNOLOGIES | 50,251 | $470.0M | 0.03% | |
| 122 | LNTHLANTHEUS HOLDINGS | 53,763 | $462.0M | 0.03% | |
| 123 | —EXPRESS SCRIPTS HOLDING | 6,639 | $457.0M | 0.03% | |
| 124 | HUMHUMANA | 2,227 | $454.0M | 0.03% | |
| 125 | AGLEUSDAEGLEA BIOTHERAPEUTICS | 103,585 | $451.0M | 0.03% | |
| 126 | HRCHILL ROM HOLDINGS | 7,930 | $445.0M | 0.03% | |
| 127 | MCKMCKESSON | 3,078 | $432.0M | 0.03% | |
| 128 | —IMMUNE DESIGN | 77,725 | $428.0M | 0.03% | |
| 129 | NVAXNOVAVAX | 335,413 | $423.0M | 0.03% | |
| 130 | —SUCAMPO PHARMACEUTICALS CLASS A | 30,694 | $416.0M | 0.03% | |
| 131 | MOHMOLINA HEALTHCARE | 6,981 | $379.0M | 0.03% | |
| 132 | RACEFERRARI | 6,200 | $360.0M | 0.03% | |
| 133 | —PHASERX | 200,000 | $310.0M | 0.02% | |
| 134 | IRIXIRIDEX | 21,885 | $308.0M | 0.02% | |
| 135 | AGENEURAGENUS | 72,187 | $297.0M | 0.02% | |
| 136 | —NIVALIS THERAPEUTICS | 122,275 | $274.0M | 0.02% | |
| 137 | SRPTSAREPTA THERAPEUTICS INC PUT 50 01/20/2017 | 10,900 | $249.0M | 0.02% | Put |
| 138 | —PERNIX THERAPEUTICS HOLD 01APR21 4.25PCT | 1,000,000 | $246.0M | 0.02% | |
| 139 | —ACASTI PHARMA CLASS A | 186,559 | $233.0M | 0.02% | |
| 140 | PBYIPUMA BIOTECHNOLOGY | 7,344 | $225.0M | 0.02% | |
| 141 | LHCGUSDLHC GROUP | 4,745 | $217.0M | 0.02% | |
| 142 | —ENDO INTERNATIONAL | 12,920 | $213.0M | 0.02% | |
| 143 | —MERRIMACK PHARMACEUTICALS | 48,910 | $200.0M | 0.01% | |
| 144 | NTLAINTELLIA THERAPEUTICS | 14,673 | $192.0M | 0.01% | |
| 145 | FSBCFIVE STAR QUALITY CARE | 67,797 | $183.0M | 0.01% | |
| 146 | —GENVEC | 56,131 | $180.0M | 0.01% | |
| 147 | PMDUSDPSYCHEMEDICS | 6,626 | $164.0M | 0.01% | |
| 148 | —AUDENTES THERAPEUTICS | 7,500 | $137.0M | 0.01% | |
| 149 | —ONCOBIOLOGICS INC WTS | 656,382 | $124.0M | 0.01% | |
| 150 | —STEMLINE THERAPEUTICS | 10,702 | $115.0M | 0.01% | |
| 151 | —AEVI GENOMIC MEDICINE WARRANT | 150,000 | $106.0M | 0.01% | |
| 152 | —CYNOSURE CLASS A | 1,800 | $82.0M | 0.01% | |
| 153 | —CEMPRA | 22,321 | $62.0M | 0.00% | |
| 154 | —IGNYTA | 6,584 | $35.0M | 0.00% | |
| 155 | VCELVERICEL | 9,385 | $28.0M | 0.00% | |
| 156 | —CHINA BIOLOGIC PRODUCTS | 236 | $25.0M | 0.00% | |
| 157 | —OPHTHOTECH CORP PUT 20 01/20/2017 | 1,600 | $24.0M | 0.00% | Put |
| 158 | BMRNBIOMARIN PHARMACEUTICAL | 250 | $21.0M | 0.00% | |
| 159 | —ARIAD PHARMACEUTICALS | 1,551 | $19.0M | 0.00% | |
| 160 | ABMDEURABIOMED | 109 | $12.0M | 0.00% | |
| 161 | WSTWEST PHARMACEUTICAL SERVICES | 138 | $12.0M | 0.00% | |
| 162 | —CAPRICOR THERAPEUTICS | 4,000 | $11.0M | 0.00% | |
| 163 | SUPNSUPERNUS PHARMACEUTICALS | 421 | $11.0M | 0.00% | |
| 164 | GKOSGLAUKOS | 300 | $10.0M | 0.00% | |
| 165 | INGNINOGEN | 125 | $8.0M | 0.00% | |
| 166 | —PEREGRINE PHARMACEUTICALS | 24,332 | $8.0M | 0.00% | |
| 167 | —SEVION THERAPEUTICS INC | 59,220 | $8.0M | 0.00% | |
| 168 | ACADACADIA PHARMACEUTICALS INC CALL 40 01/20/2017 | 100,000 | $7.0M | 0.00% | Call |
| 169 | —INNOCOLL | 9,433 | $7.0M | 0.00% | |
| 170 | —NEOS THERAPEUTICS | 1,056 | $6.0M | 0.00% | |
| 171 | —OPHTHOTECH CORP CALL 75 01/20/2017 | 200,000 | $5.0M | 0.00% | Call |
| 172 | DVAXDYNAVAX TECHNOLOGIES CALL 4 01/2017 | 15,600 | $5.0M | 0.00% | Call |
| 173 | —AVINGER | 1,062 | $4.0M | 0.00% | |
| 174 | XBISPDR SandP BIOTECH ETF | 50 | $3.0M | 0.00% | |
| 175 | LLYELI LILLY & CO CALL 90 01/20/2017 | 100,000 | $3.0M | 0.00% | Call |
| 176 | MRTXEURMIRATI THERAPEUTICS | 521 | $2.0M | 0.00% | |
| 177 | AORTCRYOLIFE | 123 | $2.0M | 0.00% | |
| 178 | GBYSANGAMO BIOSCIENCES | 272 | $1.0M | 0.00% | |
| 179 | DONSPDR DOW JONES INDUSTRIAL AVERAGE ETF | 3 | $1.0M | 0.00% | |
| 180 | —FLEX PHARMA | 237 | $1.0M | 0.00% | |
| 181 | THCTENGION INC | 1,826,399 | $1.0M | 0.00% | |
| 182 | JNJJOHNSON and JOHNSON | 2 | $0 | 0.00% | |
| 183 | DHRDANAHER | 3 | $0 | 0.00% | |
| 184 | IVVISHARES CORE SandP 500 ETF | 1 | $0 | 0.00% | |
| 185 | —IMPAX LABORATORIES | 1 | $0 | 0.00% | |
| 186 | —ALLON THERAPEUTICS | 751,124 | $0 | 0.00% | |
| 187 | BSXBOSTON SCIENTIFIC | 3 | $0 | 0.00% | |
| 188 | BRKRBRUKER | 3 | $0 | 0.00% | |
| 189 | IWSISHARES RUSSELL MID-CAP VALUE ETF | 2 | $0 | 0.00% | |
| 190 | TLTISHARES 20 PLUS YEAR TREASURY BOND ETF | 2 | $0 | 0.00% | |
| 191 | TMOTHERMO FISHER SCIENTIFIC | 2 | $0 | 0.00% | |
| 192 | —OPHTHOTECH CORP CALL 55 01/20/2017 | 20,000 | $0 | 0.00% | Call |
| 193 | —OPHTHOTECH CORP CALL 70 01/20/2017 | 400 | $0 | 0.00% | Call |
| 194 | GQ9SPDR GOLD SHARES ETF | 1 | $0 | 0.00% | |
| 195 | DVADAVITA | 3 | $0 | 0.00% | |
| 196 | CRBPEURCORBUS PHARMACEUTICALS HOLDINGS INC CALL 15 01/20/2017 | 1,600 | $0 | 0.00% | Call |
| 197 | CTLTEURCATALENT | 3 | $0 | 0.00% | |
| 198 | ZTSZOETIS CLASS A | 3 | $0 | 0.00% |
PreviousPage 2 of 2